plenti6-SLC7A11/xCT-V5 Citations (1)

Originally described in: The glutamate/cystine antiporter SLC7A11/xCT enhances cancer cell dependency on glucose by exporting glutamate.
Koppula P, Zhang Y, Shi J, Li W, Gan B J Biol Chem. 2017 Aug 25;292(34):14240-14249. doi: 10.1074/jbc.M117.798405. Epub 2017 Jun 19. PubMed Journal

---

Articles Citing plenti6-SLC7A11/xCT-V5

Articles
Inhibition of LSD1 induces ferroptosis through the ATF4-xCT pathway and shows enhanced anti-tumor effects with ferroptosis inducers in NSCLC. Du L, Yang H, Ren Y, Ding Y, Xu Y, Zi X, Liu H, He P. Cell Death Dis. 2023 Nov 3;14(11):716. doi: 10.1038/s41419-023-06238-5. PubMed

If you have published an article using this material, please email us at to have your article added to this page.